Nanotechnology in retinal drug delivery

Journal Title: International Journal of Ophthalmology - Year 2018, Vol 11, Issue 6

Abstract

Retinal diseases, including age-related macular degeneration (AMD) and diabetic retinopathy (DR) are the leading causes of blindness in adults over the age of 50 years in the US. While most of those conditions do not have a cure, currently available treatment options attempt to prevent further vision loss. For many ophthalmic drugs, an efficient delivery system to provide maximum therapeutic efficacy and promote patient compliance remains an unmet medical need. An exploration of literature via PubMed spanning from 2007 to 2017 was conducted to identify studies that have evaluated nanotechnology as platforms for delivering therapeutic agents to the posterior segment of the eye where the retina is located. Until now, four routes that have been utilized for retinal drug delivery are the intravitreal, periocular, subretinal, and systemic routes. Intravitreal injections are now widely used in clinical practice due to their ability to directly target the back of the eye but are highly invasive procedures that may cause several complications, particularly with repeated uses over a short timespan. Nanotechnology shows great promise to revolutionize retinal drug delivery, offering many advantages such as a targeted delivery system towards the specific site of the retina as well as sustained delivery of therapeutic agents. In this review, specific eye anatomy and constraints on ocular drug administration are illustrated. Further, we list and highlight several examples of nanosystems, such as hydrogels, liposomes, dendrimers, and micelles, used via different drug delivery routes to treat various retinal diseases.

Authors and Affiliations

Jianjun Chen

Keywords

Related Articles

Validity of automated refraction after segmented refractive multifocal intraocular lens implantation

"AIM: To evaluate the clinical utility of automated refraction (AR) and keratometry (KR) compared with subjective or manifest refraction (MR) after cataract or refractive lens exchange surgery with implantation of Lentis...

Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion

"AIM: To evaluate the potential role of hyperreflective foci (HF) as a prognostic indicator of visual outcome in patients with macular edema (ME) due to retinal vein occlusion (RVO). METHODS: We retrospectively reviewed...

Reactive oxygen species mediates a metabolic memory of high glucose stress signaling in bovine retinal pericytes

"AIM: To investigate the role of reactive oxygen species (ROS) and antioxidant mechanism underlying the metabolic memory of bovine retinal pericytes (BRPs) induced by high glucose. METHODS: Effects of high glucose levels...

Evaluation of the safety and efficacy of therapeutic bandage contact lenses on post-cataract surgery patients

"AIM: To evaluate the safety of therapeutic bandage contact lens for post-cataract surgery patients and to illustrate its efficacy on post-operative comfort and tear-film stability. METHODS: A total of 40 participants we...

Validation of the Glaucoma Quality of Life-15 Questionnaire in Serbian language

"AIM: To translate the Glaucoma Quality of Life-15 (GQL-15) to Serbian language and asses its validity and reliability in the population of Serbian patients. METHODS: The study included 177 glaucoma patients. Clinical pa...

Download PDF file
  • EP ID EP484238
  • DOI -
  • Views 43
  • Downloads 0

How To Cite

Jianjun Chen (2018). Nanotechnology in retinal drug delivery. International Journal of Ophthalmology, 11(6), -. https://europub.co.uk/articles/-A-484238